The US President's Emergency Plan for AIDS Relief has been a cornerstone of global HIV/AIDS prevention, care and treatment ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...

A revolutionary advancement in HIV prevention technology stands at a critical crossroads as recent policy decisions threaten ...

Missed KHOU 11+’s live Q&A on injectable PrEP? Watch on demand as experts discuss this HIV prevention breakthrough and answer ...

This year’s Conference on Retroviruses and Opportunistic Infections (CROI) features several sessions discussing prevention ...

The Elizabeth Glaser Pediatric AIDS Foundation said the latest cuts will deprive 350,000 people of HIV treatment.

| Dr. Buzón discusses bridging science and reality, highlighting the vital role of real-world evidence in advancing HIV care ...

Modern HIV treatment offers remarkable outcomes. This guide explores essential first steps, treatment advances, support ...

Clinical Trial Reveals Twice-Yearly Injection to Be 96% Effective in HIV Prevention Nov. 27, 2024 — Recent results from a recent clinical trial indicate that a twice-yearly injection of ...

The FDA has accepted under Priority Review the NDA for lenacapavir for the prevention of HIV as pre-exposure prophylaxis.

The possibility of ending the HIV epidemic in Europe is more tangible than ever, but the actions we take now will determine ...

Mississippi is grappling with some of the highest rates of sexually transmitted infections in the country, including ...